Antitrust

Antitrust Challenge Permitted by FTC v. Actavis May Be Limited

In June 2013, the U.S. Supreme Court released its decision on “reverse payment” settlements between brand-name and generic drug makers. […]

Daily Updates

Sign up for our free daily newsletter for the latest news and business legal developments.

Scroll to Top